Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

N-Acetyl lysyltyrosylcysteine amide

Catalog No. T38063Cas No. 1287585-40-3

N-Acetyl lysyltyrosylcysteine amide is a non-toxic, potent, reversible, and specific myeloperoxidase (MPO) tripeptide inhibitor that effectively inhibits MPO production in vivo, attenuates neuronal damage, preserves brain tissue and neurological function post-stroke, and inhibits MPO-dependent hypochlorite (HOCl) production, protein nitration, and LDL oxidation. It is also used in the study of bronchial dysplasia.

N-Acetyl lysyltyrosylcysteine amide

N-Acetyl lysyltyrosylcysteine amide

Purity: 98.08%
Catalog No. T38063Cas No. 1287585-40-3
N-Acetyl lysyltyrosylcysteine amide is a non-toxic, potent, reversible, and specific myeloperoxidase (MPO) tripeptide inhibitor that effectively inhibits MPO production in vivo, attenuates neuronal damage, preserves brain tissue and neurological function post-stroke, and inhibits MPO-dependent hypochlorite (HOCl) production, protein nitration, and LDL oxidation. It is also used in the study of bronchial dysplasia.
Pack SizePriceAvailabilityQuantity
1 mg$72In Stock
5 mg$183In Stock
10 mg$313In Stock
25 mg$528In Stock
50 mg$753In Stock
100 mg$987In Stock
500 mg$1,980In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "N-Acetyl lysyltyrosylcysteine amide"

Select Batch
Purity:98.08%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
N-Acetyl lysyltyrosylcysteine amide is a non-toxic, potent, reversible, and specific myeloperoxidase (MPO) tripeptide inhibitor that effectively inhibits MPO production in vivo, attenuates neuronal damage, preserves brain tissue and neurological function post-stroke, and inhibits MPO-dependent hypochlorite (HOCl) production, protein nitration, and LDL oxidation. It is also used in the study of bronchial dysplasia.
In vivo
N-Acetyl lysyltyrosylcysteine amide (KYC) (10 mg/kg; i.p.; daily for 3-7 days; C57BL/6J mice) significantly reduces neurological severity scores and infarct size in MCAO mice.[1]
N-Acetyl lysyltyrosylcysteine amide (10 mg/kg; i.p.; daily for 7 days) significantly protects BBB function and decreased neutrophil infiltration.[1]
N-Acetyl lysyltyrosylcysteine amide (10 mg/kg; i.p.; daily for 7 days; C57BL/6J mice) significantly reduces microglia/macrophage activation and neuron loss in MCAO mice.[1]
N-Acetyl lysyltyrosylcysteine amide (10 mg/kg; i.p.; daily for 3-7 days; C57BL/6J mice) decreases apoptosis and cell injury in the brains of MCAO mice.[1]
N-Acetyl lysyltyrosylcysteine amide reduced MPO in the brains of MCAO mice. N-Acetyl lysyltyrosylcysteine amide reduces NO2Tyr and 4-HNE in MCAO mice. N-Acetyl lysyltyrosylcysteine amide significantly decreases infarct size, blood-brain barrier leakage, infiltration of myeloid cells, loss of neurons, and apoptosis in the brains of middle cerebral artery occlusion (MCAO) mice.[1]
Chemical Properties
Molecular Weight453.56
FormulaC20H31N5O5S
Cas No.1287585-40-3
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 55 mg/mL (121.26 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.2048 mL11.0239 mL22.0478 mL110.2390 mL
5 mM0.4410 mL2.2048 mL4.4096 mL22.0478 mL
10 mM0.2205 mL1.1024 mL2.2048 mL11.0239 mL
20 mM0.1102 mL0.5512 mL1.1024 mL5.5119 mL
50 mM0.0441 mL0.2205 mL0.4410 mL2.2048 mL
100 mM0.0220 mL0.1102 mL0.2205 mL1.1024 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy N-Acetyl lysyltyrosylcysteine amide | purchase N-Acetyl lysyltyrosylcysteine amide | N-Acetyl lysyltyrosylcysteine amide cost | order N-Acetyl lysyltyrosylcysteine amide | N-Acetyl lysyltyrosylcysteine amide chemical structure | N-Acetyl lysyltyrosylcysteine amide in vivo | N-Acetyl lysyltyrosylcysteine amide formula | N-Acetyl lysyltyrosylcysteine amide molecular weight